Search the Journal

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

VOLUME 33: NO. 5 MAY 2006

Editorials

Anti-Tumor Necrosis Factor-a Agents for Rheumatoid Arthritis: Assessing Longterm Safety

K.L. Hyrich, A.J. Silman.........831

Quantitative Clinical Rheumatology The DAS Is the Most Specific Measure, But a Patient Questionnaire Is the Most Informative Measure to Assess Rheumatoid Arthritis

T. Pincus.........834

Identifying Those at Risk of Developing Persistent Pain Following a Motor Vehicle Collision

M. Sterling.........838

Classification in Systemic Sclerosis

S.R. Johnson, R.M. Laxer.........840

Articles

Role of SLC22A4, SLC22A5, and RUNX1 Genes in RA

A. Martínez, A. Valdivia, D. Pascual-Salcedo, et al.........842

A Phase I Study Assessing the Safety, Clinical Response, and Pharmacokinetics of an Experimental Infliximab Formulation for Subcutaneous or Intramuscular Administration in Patients with RA

R. Westhovens, F. Houssiau, J. Joly, et al .........847

Etanercept Treatment in Adults with Established RA: 7 Years of Clinical Experience

L.W. Moreland, M.E. Weinblatt, E.C. Keystone, et al.........854

Controlled Trial of MTX versus CH-1504 in the Treatment of
RA


O. Castaneda, M.G. Nair.........862

Safety of Infliximab Used in Combination with Leflunomide or Azathioprine in Daily Clinical Practice

A. Perdriger, X. Mariette, J-L. Kuntz, et al .........865

Patient's Ethnicity Does Not Influence Utilization of Effective Therapies in RA

D.C. Ang, H.E. Paulus, J.S. Louie.........870

Functional Health Literacy of Patients with RA Attending a Community-Based Rheumatology Practice

R. Buchbinder, S. Hall, J.M. Youd.........879

Parvovirus B19 Infection in Patients with RA in Taiwan

Y-S. Chen, P-H. Chou, S-N. Li, et al .........887

Survival Analysis and Longterm Results of Elbow Synovectomy in RA

M. Fuerst, B. Fink, W. Rüther.........892

Laboratory and Imaging Studies Used by French Rheumatologists to Evaluate Patients with Early Arthritis

A. Saraux, B. Fautrel, J.F. Maillefert, et al .........897

Role of Endothelial Damage in the Pathogenesis of Interstitial Pneumonitis in Patients with PM and DM

M. Funauchi, H. Shimadsu, C. Tamaki, et al.........903

Validity of Screening Tests for SS in Ambulatory Patients with Chronic Diseases

J. Sánchez-Guerrero, M.R. Pérez-Dosal, E. Celis-Aguilar, et al.........907

Cepharanthin, a Biscoclaurine Alkaloid, Prevents Destruction of Acinar Tissues in Murine SS

M. Azuma, Y. Ashida, T. Tamatani, et al.........912

Effects of Infliximab Treatment on Lipoprotein Profile in Patients with RA and AS

D.N. Kiortsis, A.K. Mavridis, T.D. Filippatos, S. Vasakos, S.N. Nikas, A.A. Drosos.........921

Patients with PsA Have an Increased Number of Lymphocytes in the Duodenal Mucosa in Comparison with Patients with Psoriasis Vulgaris

U. Lindqvist, G. Kristjánsson, I. Pihl-Lundin, E. Hagforsen, G. Michaëlsson.........924

Characterization of an Activation Factor Released from Human Neutrophils After Stimulation by Triclinic MSU Crystals

P. Desaulniers, S. Marois, G. Paré, O. Popa-Nita, C. Gilbert, P.H. Naccache .........928

Ambulatory Physical Activity, Disease Severity, and Employment Status in Adult Women with OA of the Hip

S. Hirata, R. Ono, M. Yamada, et al.........939

Longterm Effects of Intraarticular Hyaluronan on Synovial Fluid in OA of the Knee

H. Bagga, D. Burkhardt, P. Sambrook, L. March.........946

A Prospective, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy of Intraarticular Hyaluronic Acid for OA of the Knee

R.J. Petrella, M. Petrella.........951

Medicinal and Injection Therapies for Mechanical Neck Disorders: A Cochrane Systematic Review

P.M. Peloso, A.R. Gross, T.A. Haines, et al.........957

Predicting New Onset of Widespread Pain Following a Motor Vehicle Collision

G. Wynne-Jones, G.T. Jones, N.J. Wiles, A.J. Silman, G.J. Macfarlane .........968

Alberta Rodeo Athletes Do Not Develop the Chronic Whiplash Syndrome

A.L. Shannon, R. Ferrari, A.S. Russell.........975

Meeting Report Summary of the 2005 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)

M.M. Ward, J. Bruckel, R. Colbert, et al.........978

Meeting Report Panamerican Congress of Spondyloarthropathies, Cartagena, Colombia, October 20-22, 2005: Latin American Rheumatology Comes of Age!

R. Valle, D. Yu, L.R. Espinoza.........983

Pediatric Rheumatology

Evaluation of the Comparative Efficacy and Tolerability of Rofecoxib and Naproxen in Children and Adolescents with JRA: A 12-Week Randomized Controlled Clinical Trial with a 52-Week Open-Label Extension

A. Reiff, D.J. Lovell, J. van Adelsberg, et al .........985

Clinical Significance of Decreased Serum Concentration of Cartilage Oligomeric Matrix Protein in Systemic JIA

T. Urakami, A. Manki, T. Inoue, M. Oda, H. Tanaka, T. Morishima.........996

BMD and Turnover in Non-Corticosteroid Treated African American Children with JRA

A.J. Head, L.K. Myers, M.A. Watsky, et al.........1001

Childhood Onset SSc: Classification, Clinical and Serologic Features, and Survival in Comparison with Adult Onset Disease

K. Scalapino, T. Arkachaisri, M. Lucas, et al.........1004

TNF-a Inhibition and VATER Association: A Causal Relationship?

J.D. Carter, J. Valeriano, F.B. Vasey.........1014

 

Case Reports

Neurological Complications of Infliximab

J. Jarand, D.W. Zochodne, L.O. Martin, C. Voll .........1018

Rituximab as Therapy for Refractory PM and DM

E.H. Noss, D.L. Hausner-Sypek, M.E. Weinblatt.........1021

Letters

Association of RA with Multiple Sclerosis: Report of 14 Cases and Discussion of Its Significance

E. Toussirot, E. Pertuiset, A. Martin, et al .........1027

Regulation of Killer Immunoglobulin-like Receptors in SLE

T. Momot, R.E. Schmidt, T. Witte.........1029

Angry Fat

D.L. Jardine, J. Gardner, R. Steele.........1030

Meetings in Rheumatology



Return to Archives



© 2006. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.